David S Goldstein
Overview
Explore the profile of David S Goldstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
271
Citations
8768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Walitt B, Singh K, LaMunion S, Hallett M, Jacobson S, Chen K, et al.
Nat Commun
. 2024 Feb;
15(1):907.
PMID: 38383456
Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling disorder, yet the clinical phenotype is poorly defined, the pathophysiology is unknown, and no disease-modifying treatments are available. We used rigorous...
12.
Millar Vernetti P, Norcliffe-Kaufmann L, Palma J, Biaggioni I, Shibao C, Peltier A, et al.
Brain
. 2024 Feb;
147(7):2440-2448.
PMID: 38366572
We aimed to describe the clinical features of patients with pure autonomic failure (PAF) preceding phenoconversion that could be useful as predictive markers for advancing α-synuclein-associated neurodegeneration of the brain....
13.
Goldstein D
J Pers Med
. 2024 Jan;
14(1).
PMID: 38276245
Dysautonomias are conditions in which altered functions of one or more components of the autonomic nervous system (ANS) adversely affect health. This essay is about how elucidating mechanisms of dysautonomias...
14.
Goldstein D
Nat Rev Neurol
. 2024 Jan;
20(2):99-113.
PMID: 38212633
Following on from the COVID-19 pandemic is another worldwide public health challenge that is referred to variously as long COVID, post-COVID syndrome or post-acute sequelae of SARS-CoV-2 infection (PASC). PASC...
15.
16.
Goldstein D, Holmes C, Sullivan P, Lopez G, Gelsomino J, Moore S, et al.
J Clin Invest
. 2023 Oct;
134(1).
PMID: 37883190
Background: In Lewy body diseases (LBDs) Parkinson disease (PD), and dementia with Lewy bodies (DLB), by the time parkinsonism or cognitive dysfunction manifests clinically, substantial neurodegeneration has already occurred. Biomarkers...
17.
Lenka A, Isonaka R, Holmes C, Goldstein D
Clin Auton Res
. 2023 Oct;
33(6):737-747.
PMID: 37843677
Purpose: Pure autonomic failure (PAF) is a rare disease characterized by neurogenic orthostatic hypotension (nOH), no known secondary cause, and lack of a neurodegenerative movement or cognitive disorder. Clinically diagnosed...
18.
Lenka A, Isonaka R, Holmes C, Goldstein D
Res Sq
. 2023 Jul;
PMID: 37503103
Background: Pure autonomic failure (PAF) is a rare disease characterized clinically by neurogenic orthostatic hypotension (nOH) and biochemically by peripheral noradrenergic deficiency. Clinically diagnosed PAF can evolve ("phenoconvert") to a...
19.
20.
Tamaoki N, Siebert S, Maeda T, Ha N, Good M, Huang Y, et al.
Cell Rep Methods
. 2023 May;
3(4):100460.
PMID: 37159663
Although the differentiation of human induced pluripotent stem cells (hiPSCs) into various types of blood cells has been well established, approaches for clinical-scale production of multipotent hematopoietic progenitor cells (HPCs)...